相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Olanzapine plus aprepitant, palonosetron, and dexamethasone for nausea and vomiting in patients with breast cancer receiving anthracycline: A retrospective study
Hitoshi Kawazoe et al.
SCIENTIFIC REPORTS (2018)
Temozolomide increases MHC-I expression via NF-κB signaling in glioma stem cells
Dongyong Zhang et al.
CELL BIOLOGY INTERNATIONAL (2017)
Olanzapine modulation of hepatic oxidative stress and inflammation in socially isolated rats
Nevena Todorovic et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Mesenchymal stem cells promote colorectal cancer progression through AMPK/mTOR-mediated NF-κB activation
Xiao-Bing Wu et al.
SCIENTIFIC REPORTS (2016)
CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer
Alice Nomura et al.
ONCOTARGET (2015)
Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect
Georg Karpel-Massler et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Autophagy Involvement in Olanzapine-Mediated Cytotoxic Effects in Human Glioma Cells
Yi-Xuan Wang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Dihydroartemisinin induces autophagy by suppressing NF-κB activation
Wei Hu et al.
CANCER LETTERS (2014)
Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects
Silje Skrede et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Survival and Death Strategies in Glioma Cells: Autophagy, Senescence and Apoptosis Triggered by a Single Type of Temozolomide-Induced DNA Damage
Anna V. Knizhnik et al.
PLOS ONE (2013)
Olanzapine Activates Hepatic Mammalian Target of Rapamycin: New Mechanistic Insight into Metabolic Dysregulation with Atypical Antipsychotic Drugs
Robin H. Schmidt et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Valproic Acid Downregulates the Expression of MGMT and Sensitizes Temozolomide-Resistant Glioma Cells
Chung Heon Ryu et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Activation of AMP-activated Protein Kinase by Temozolomide Contributes to Apoptosis in Glioblastoma Cells via p53 Activation and mTORC1 Inhibition
Wen-bin Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors
Shona L. Kirk et al.
PSYCHOPHARMACOLOGY (2009)
The signaling adaptor p62 is an important NF-κB mediator in tumorigenesis
Angeles Duran et al.
CANCER CELL (2008)
NF-kappaB: a potential target for cancer chemoprevention and therapy
Fazlul H. Sarkar et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Autophagy fights disease through cellular self-digestion
Noboru Mizushima et al.
NATURE (2008)
Novel mechanism whereby nuclear factor κB mediates DNA damage repair through regulation of O6-methylguanine-DNA-methyltransferase
Iris Lavon et al.
CANCER RESEARCH (2007)
Class III β-tubulin and γ-tubulin are co-expressed and form complexes in human glioblastoma cells
Christos D. Katsetos et al.
NEUROCHEMICAL RESEARCH (2007)
Potential therapeutic applications of autophagy
David C. Rubinsztein et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
NF-κB activation represses tumor necrosis factor-α-induced autophagy
Mojgan Djavaheri-Mergny et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The signaling adapter p62 is an important mediator of T helper 2 cell function and allergic airway inflammation
Pilar Martin et al.
EMBO JOURNAL (2006)
Maturation of autophagic vacuoles in mammalian cells
Eeva-Liisa Eskelinen
AUTOPHAGY (2005)
NF-κB functions as a tumour promoter in inflammation-associated cancer
E Pikarsky et al.
NATURE (2004)
Autophagy in health and disease: A double-edged sword
T Shintani et al.
SCIENCE (2004)
Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas
KD Weaver et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Aberrant nuclear factor-κB activity and its participation in the growth of human malignant astrocytoma
S Nagai et al.
JOURNAL OF NEUROSURGERY (2002)
NF-kappa B at the crossroads of life and death
M Karin et al.
NATURE IMMUNOLOGY (2002)
Expression of nuclear factor-κB, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas
S Hayashi et al.
NEUROLOGIA MEDICO-CHIRURGICA (2001)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)